Piruz Nahreini

1.1k citations
35 papers · 890 indexed · h-index 16
Topics
Neuroblastoma Research and Treatments (9 papers)Virus-based gene therapy research (7 papers)Signaling Pathways in Disease (7 papers)
Partner nations
United StatesFrance

In The Last Decade

Piruz Nahreini

35 papers receiving 875 citations

Peers

Piruz Nahreini
Comparison fields: 5 of 94
  • Molecular Biology 472
  • Genetics 216
  • Immunology 171
  • Epidemiology 161
  • Physiology 109
Replace Maria Ripoli with:
Maria Ripoli Italy
Stacey Arnold United States
Christopher D. Kane United States
Carole Brasse‐Lagnel France
Laura Cuomo Italy
Shiuan Wey United States
Anna De Gaetano Italy
Scott M. Plafker United States
Svetlana M. Nabokina United States
Saška Ivanova Russia
Piruz Nahreini relative to Maria Ripoli Italy Maria Ripoli's profile →
Citations per field
00.5×1.5×2.1×
Maria Ripoli · 1×
Citations per year

Countries citing papers authored by Piruz Nahreini

Since Specialization
Citations

This map shows the geographic impact of Piruz Nahreini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piruz Nahreini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piruz Nahreini more than expected).

Fields of papers citing papers by Piruz Nahreini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piruz Nahreini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piruz Nahreini. The network helps show where Piruz Nahreini may publish in the future.

Co-authorship network of co-authors of Piruz Nahreini

This figure shows the co-authorship network connecting the top 25 collaborators of Piruz Nahreini. A scholar is included among the top collaborators of Piruz Nahreini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piruz Nahreini. Piruz Nahreini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 118
2 132
3 1
4 1
5 10
6 13
7 18
8 8
9 8
10 17
11 28
12 19
13 36
14 64
15 58
16 5
17 104
18 36
19 20
20 5

About Piruz Nahreini

Piruz Nahreini is a scholar working on Physiology, Neurology and Virology, having authored 35 papers that have together received 890 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (9 papers), Virus-based gene therapy research (7 papers) and Signaling Pathways in Disease (7 papers). The work is most often cited by research in Immunology (171 citations), Genetics (216 citations) and Molecular Biology (472 citations). Piruz Nahreini has collaborated with scholars based in United States and France. Frequent co-authors include Kedar N. Prasad, Arun Srivastava, Alicia R. Hovland, Judith Edwards‐Prasad, Jieru Wang, Robert J. Mason, Kevan L. Hartshorn, Bipin Kumar, Shang Zhen Zhou and William C. Cole. Their work appears in journals such as PLoS ONE, Oncogene and Journal of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026